{"id":"https://openalex.org/W2083174479","doi":"https://doi.org/10.1128/aac.01118-07","title":"Connection between Trimethoprim-Sulfamethoxazole Use and Resistance in Streptococcus pneumoniae, Haemophilus influenzae , and Moraxella catarrhalis","display_name":"Connection between Trimethoprim-Sulfamethoxazole Use and Resistance in Streptococcus pneumoniae, Haemophilus influenzae , and Moraxella catarrhalis","publication_year":2008,"publication_date":"2008-04-29","ids":{"openalex":"https://openalex.org/W2083174479","doi":"https://doi.org/10.1128/aac.01118-07","mag":"2083174479","pmid":"https://pubmed.ncbi.nlm.nih.gov/18443116","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2443875"},"language":"en","primary_location":{"id":"doi:10.1128/aac.01118-07","doi":"https://doi.org/10.1128/aac.01118-07","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.01118-07","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2443875","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056701892","display_name":"Pauliina K\u00e4rp\u00e4noja","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pauliina Ka\u0308rpa\u0308noja","raw_affiliation_strings":["Pa\u0308ija\u0308t-Ha\u0308me Social and Health Care Group, Clinical Microbiology, Lahti, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pa\u0308ija\u0308t-Ha\u0308me Social and Health Care Group, Clinical Microbiology, Lahti, Finland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039375684","display_name":"Solja T. Nyberg","orcid":"https://orcid.org/0000-0001-5181-2402","observed_orcids":["https://orcid.org/0000-0001-5181-2402"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Solja T. Nyberg","raw_affiliation_strings":["National Public Health Institute, Department of Human Microbial Ecology and Inflammation, Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Public Health Institute, Department of Human Microbial Ecology and Inflammation, Turku, Finland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055669129","display_name":"Miika Bergman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Miika Bergman","raw_affiliation_strings":["National Public Health Institute, Department of Bacterial and Inflammatory Diseases, Antimicrobial Research Laboratory, Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Public Health Institute, Department of Bacterial and Inflammatory Diseases, Antimicrobial Research Laboratory, Turku, Finland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000757654","display_name":"Tinna Voipio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150926","display_name":"Finnish Medicines Agency Fimea","ror":"https://ror.org/04mjpp490","country_code":"FI","type":"government","lineage":["https://openalex.org/I4210150926","https://openalex.org/I4210159665"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Tinna Voipio","raw_affiliation_strings":["National Agency for Medicines, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Agency for Medicines, Helsinki, Finland","institution_ids":["https://openalex.org/I4210150926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027887051","display_name":"Pirkko Paakkari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150926","display_name":"Finnish Medicines Agency Fimea","ror":"https://ror.org/04mjpp490","country_code":"FI","type":"government","lineage":["https://openalex.org/I4210150926","https://openalex.org/I4210159665"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Pirkko Paakkari","raw_affiliation_strings":["National Agency for Medicines, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Agency for Medicines, Helsinki, Finland","institution_ids":["https://openalex.org/I4210150926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077503732","display_name":"Pentti Huovinen","orcid":"https://orcid.org/0000-0003-0003-1539","observed_orcids":["https://orcid.org/0000-0003-0003-1539"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pentti Huovinen","raw_affiliation_strings":["National Public Health Institute, Department of Human Microbial Ecology and Inflammation, Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Public Health Institute, Department of Human Microbial Ecology and Inflammation, Turku, Finland","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066658717","display_name":"Hannu Sarkkinen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hannu Sarkkinen","raw_affiliation_strings":["Pa\u0308ija\u0308t-Ha\u0308me Social and Health Care Group, Clinical Microbiology, Lahti, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pa\u0308ija\u0308t-Ha\u0308me Social and Health Care Group, Clinical Microbiology, Lahti, Finland","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.7852,"has_fulltext":false,"cited_by_count":34,"citation_normalized_percentile":{"value":0.95255212,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"52","issue":"7","first_page":"2480","last_page":"2485"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.9038000106811523,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.9038000106811523,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.05220000073313713,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10654","display_name":"Pneumonia and Respiratory Infections","score":0.04089999943971634,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trimethoprim-sulfamethoxazole","display_name":"trimethoprim-sulfamethoxazole","score":0.9959999918937683},{"id":"https://openalex.org/keywords/antimicrobial-resistance","display_name":"antimicrobial resistance","score":0.9700000286102295},{"id":"https://openalex.org/keywords/streptococcus-pneumoniae","display_name":"Streptococcus pneumoniae","score":0.9570000171661377},{"id":"https://openalex.org/keywords/haemophilus-influenzae","display_name":"Haemophilus influenzae","score":1.0},{"id":"https://openalex.org/keywords/moraxella-catarrhalis","display_name":"Moraxella catarrhalis","score":1.0},{"id":"https://openalex.org/keywords/respiratory-pathogens","display_name":"respiratory pathogens","score":0.7839999794960022},{"id":"https://openalex.org/keywords/drug-use","display_name":"drug use","score":0.6389999985694885},{"id":"https://openalex.org/keywords/antimicrobial-stewardship","display_name":"antimicrobial stewardship","score":0.7979999780654907},{"id":"https://openalex.org/keywords/finland","display_name":"Finland","score":0.5090000033378601}],"concepts":[{"id":"https://openalex.org/C2776551000","wikidata":"https://www.wikidata.org/wiki/Q2046669","display_name":"Moraxella catarrhalis","level":4,"score":0.9467372298240662},{"id":"https://openalex.org/C2780728791","wikidata":"https://www.wikidata.org/wiki/Q422665","display_name":"Trimethoprim","level":3,"score":0.8712016344070435},{"id":"https://openalex.org/C2781253189","wikidata":"https://www.wikidata.org/wiki/Q221179","display_name":"Streptococcus pneumoniae","level":3,"score":0.8492873311042786},{"id":"https://openalex.org/C2779425571","wikidata":"https://www.wikidata.org/wiki/Q415843","display_name":"Sulfamethoxazole","level":3,"score":0.8385270833969116},{"id":"https://openalex.org/C2776925733","wikidata":"https://www.wikidata.org/wiki/Q1141979","display_name":"Haemophilus influenzae","level":3,"score":0.8009039163589478},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.7455471158027649},{"id":"https://openalex.org/C2910443534","wikidata":"https://www.wikidata.org/wiki/Q2046669","display_name":"Moraxella (Branhamella) catarrhalis","level":5,"score":0.4951612055301666},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.4405430555343628},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.4328070282936096},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.42353811860084534},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.2775156497955322}],"mesh":[{"descriptor_ui":"D001936","descriptor_name":"Moraxella catarrhalis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001936","descriptor_name":"Moraxella catarrhalis","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D005387","descriptor_name":"Finland","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006192","descriptor_name":"Haemophilus Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006192","descriptor_name":"Haemophilus Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D006193","descriptor_name":"Haemophilus influenzae","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006193","descriptor_name":"Haemophilus influenzae","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011018","descriptor_name":"Pneumonia, Pneumococcal","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011018","descriptor_name":"Pneumonia, Pneumococcal","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D012141","descriptor_name":"Respiratory Tract Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012141","descriptor_name":"Respiratory Tract Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D013296","descriptor_name":"Streptococcus pneumoniae","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D013296","descriptor_name":"Streptococcus pneumoniae","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D015662","descriptor_name":"Trimethoprim, Sulfamethoxazole Drug Combination","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015662","descriptor_name":"Trimethoprim, Sulfamethoxazole Drug Combination","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015662","descriptor_name":"Trimethoprim, Sulfamethoxazole Drug Combination","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D024881","descriptor_name":"Drug Resistance, Bacterial","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045828","descriptor_name":"Moraxellaceae Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D045828","descriptor_name":"Moraxellaceae Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1128/aac.01118-07","doi":"https://doi.org/10.1128/aac.01118-07","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.01118-07","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:1930445","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2443875","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:2443875","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2443875","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:18443116","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18443116","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Comparative Study"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:1930445","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2443875","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W31873520","https://openalex.org/W1979876370","https://openalex.org/W2029800232","https://openalex.org/W2032756342","https://openalex.org/W2084883112","https://openalex.org/W2096526472","https://openalex.org/W2100139860","https://openalex.org/W2101258244","https://openalex.org/W2103261508","https://openalex.org/W2104346641","https://openalex.org/W2119240876","https://openalex.org/W2120385320","https://openalex.org/W2132279294","https://openalex.org/W2141878952","https://openalex.org/W2143697487","https://openalex.org/W2147675307","https://openalex.org/W2151946759","https://openalex.org/W2153028278","https://openalex.org/W2154858303","https://openalex.org/W2157055942","https://openalex.org/W2167679486","https://openalex.org/W2169032813","https://openalex.org/W2321640152","https://openalex.org/W4237183685"],"related_works":["https://openalex.org/W2153028278","https://openalex.org/W2462309183","https://openalex.org/W1982049166","https://openalex.org/W2048602252","https://openalex.org/W2003184321","https://openalex.org/W2068899568","https://openalex.org/W2032756342","https://openalex.org/W7007787272","https://openalex.org/W1586458800","https://openalex.org/W2153686999"],"abstract_inverted_index":{"The":[0],"association":[1],"between":[2,73,84],"trimethoprim-sulfamethoxazole":[3,55,86,111,120,134],"use":[4,87],"and":[5,47,76,88,93],"resistance":[6,24,89,112,132],"among":[7,90,135],"the":[8,20,26,58,63,108],"major":[9],"respiratory":[10],"tract":[11],"pathogens":[12,137],"was":[13,71,82],"investigated":[14],"by":[15,115],"comparing":[16],"regional":[17,23,74,85],"consumption":[18,75],"of":[19,38,110,127],"drug":[21],"to":[22,98,133],"in":[25,29,34,105],"following":[27],"year":[28],"21":[30],"central":[31],"hospital":[32],"districts":[33],"Finland.":[35],"A":[36],"total":[37],"23,530":[39],"Streptococcus":[40],"pneumoniae":[41,65],"isolates,":[42,46,66],"28,320":[43],"Haemophilus":[44],"influenzae":[45,92],"14,138":[48],"Moraxella":[49],"catarrhalis":[50,95],"isolates":[51],"were":[52],"tested":[53],"for":[54],"susceptibility":[56],"during":[57],"study":[59],"period":[60],"(1998-2004).":[61],"Among":[62],"S.":[64],"a":[67],"statistically":[68,79],"significant":[69,80],"connection":[70,81],"found":[72,83],"resistance.":[77],"No":[78],"H.":[91],"M.":[94],"isolates.":[96],"According":[97],"our":[99],"results,":[100],"it":[101],"seems":[102],"that":[103],"only":[104],"pneumococci":[106],"can":[107],"development":[109],"be":[113],"influenced":[114],"restricting":[116],"its":[117,128],"use.":[118],"However,":[119],"remains":[121],"an":[122],"important":[123],"antimicrobial":[124],"agent":[125],"because":[126],"reasonable":[129],"price.":[130],"Hence,":[131],"these":[136],"needs":[138],"continuous":[139],"monitoring.":[140]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}